Literature DB >> 8470778

Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar.

F Migot1, C Chougnet, L Raharimalala, P Astagneau, J P Lepers, P Deloron.   

Abstract

A resurgence of falciparum malaria occurred in the central highlands of Madagascar in the 1980s and was responsible for an outbreak in 1986-1987. Since 1989, transmission has decreased dramatically. In April 1991, we investigated the humoral and cellular immune responses of 53 inhabitants of the village of Manarintsoa to six synthetic peptides that reproduced the major B and/or T cell epitopes of the Pfl 55/ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum. The presence of RESA peptide-reactive T cells was assessed by lymphocyte proliferation assay as well as by detection of in vitro production of interferon-gamma and interleukin-2. The mean values of these cellular responses were low, and the results obtained in these three tests showed no correlation. Twenty-seven subjects presented with anti-RESA antibodies as detected by modified immunofluorescent assay, but the mean levels of anti-peptide antibodies were low. When compared with data obtained in January 1988 from the same subjects with three of the six peptides, the present data demonstrated a decrease in the response to these peptides in terms of both proliferative response and mean antibody titers. The mean values of anti-RESA antibodies remained unchanged. The fact that cellular and humoral responses to the major Pfl 55/RESA epitopes decreased but did not disappear probably reflects both the remainder of the acquired immunity resulting from the 1986-1987 malaria outbreak, and its conservation by the very low level of transmission since 1989.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470778     DOI: 10.4269/ajtmh.1993.48.432

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.

Authors:  C C John; P O Sumba; J H Ouma; B L Nahlen; C L King; J W Kazura
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Anti-malaria antibody-producing B cell frequencies in adults after a Plasmodium falciparum outbreak in Madagascar.

Authors:  F Migot; C Chougnet; D Henzel; B Dubois; R Jambou; N Fievet; P Deloron
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

3.  Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Authors:  Cleopatra K Mugyenyi; Salenna R Elliott; Xi Zen Yap; Gaoqian Feng; Philippe Boeuf; Gregory Fegan; Faith F H Osier; Freya J I Fowkes; Marion Avril; Thomas N Williams; Kevin Marsh; James G Beeson
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

4.  Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.

Authors:  Francis Maina Ndungu; Ally Olotu; Jedidah Mwacharo; Mary Nyonda; Jordan Apfeld; Lazarus K Mramba; Gregory W Fegan; Philip Bejon; Kevin Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

5.  P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.

Authors:  Philip Eckhoff
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans.

Authors:  Anne C Teirlinck; Matthew B B McCall; Meta Roestenberg; Anja Scholzen; Rob Woestenenk; Quirijn de Mast; Andre J A M van der Ven; Cornelus C Hermsen; Adrian J F Luty; Robert W Sauerwein
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

7.  Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria.

Authors:  Cyril Badaut; Léa Guyonnet; Jacqueline Milet; Emmanuelle Renard; Rémy Durand; Firmine Viwami; Gratien Sagbo; Francis Layla; Philippe Deloron; Serge Bonnefoy; Florence Migot-Nabias
Journal:  Malar J       Date:  2015-07-16       Impact factor: 2.979

Review 8.  Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria.

Authors:  Michelle J Boyle; Linda Reiling; Faith H Osier; Freya J I Fowkes
Journal:  Int J Parasitol       Date:  2016-07-20       Impact factor: 3.981

9.  Cytokine profiling in immigrants with clinical malaria after extended periods of interrupted exposure to Plasmodium falciparum.

Authors:  Gemma Moncunill; Alfredo Mayor; Azucena Bardají; Laura Puyol; Augusto Nhabomba; Diana Barrios; Ruth Aguilar; María-Jesús Pinazo; Mercè Almirall; Cristina Soler; José Muñoz; Joaquim Gascón; Carlota Dobaño
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria.

Authors:  Gemma Moncunill; Alfredo Mayor; Alfons Jiménez; Augusto Nhabomba; Núria Casas-Vila; Laura Puyol; Joseph J Campo; Maria Nelia Manaca; Ruth Aguilar; María-Jesús Pinazo; Mercè Almirall; Cristina Soler; José Muñoz; Azucena Bardají; Evelina Angov; Sheetij Dutta; Chetan E Chitnis; Pedro L Alonso; Joaquim Gascón; Carlota Dobaño
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.